review·The Lancet Neurology·Jul 11, 2017GREEN OA

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

GBGiovanni B. FrisoniCorresponding authorMBMarina BoccardiFBFrederik BarkhofKBKaj BlennowSFStefano F. Cappa

University of Geneva · University Hospital of Geneva · +39 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

626
total citations
FWCI
40.38
Percentile
100%
References
96
Citations per year

Authors

48
  • GB
    Giovanni B. FrisoniCorresponding

    University of Geneva, University Hospital of Geneva, Geneva College

  • MB
    Marina Boccardi

    University of Geneva, Centro San Giovanni di Dio Fatebenefratelli

  • FB
    Frederik Barkhof

    University College London, Amsterdam UMC Location Vrije Universiteit Amsterdam

  • KB
    Kaj Blennow

    Sahlgrenska University Hospital, University of Gothenburg

  • SF
    Stefano F. Cappa

    Istituto Universitario di Studi Superiori di Pavia, Amsterdam UMC Location Vrije Universiteit Amsterdam

Topics & keywords

Topics
  • Primary topicDementia and Cognitive Impairment Research100%
  • Cancer-related cognitive impairment studies100%
  • Frailty in Older Adults100%
Keywords
  • Disease
  • Medicine
  • Reimbursement
  • Biomarker
  • Neuroimaging
  • Biomarker discovery
  • Dementia
  • Alzheimer's disease
No related works found for this paper.

Funding

  • SN
    Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • MR
    Medical Research Council
    Award: MR/L023784/2